Uranium
Compare Stocks
4 / 10Stock Comparison
NXE vs XOM vs CVX vs CCJ
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Uranium
NXE vs XOM vs CVX vs CCJ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Uranium | Oil & Gas Integrated | Oil & Gas Integrated | Uranium |
| Market Cap | $8.18B | $620.85B | $364.18B | $51.67B |
| Revenue (TTM) | $0.00 | $323.90B | $184.43B | $3.48B |
| Net Income (TTM) | $-415M | $28.84B | $12.30B | $589M |
| Gross Margin | — | 21.7% | 30.4% | 29.4% |
| Operating Margin | — | 10.5% | 9.0% | 17.5% |
| Forward P/E | — | 14.8x | 15.0x | 74.0x |
| Total Debt | $586M | $43.54B | $46.74B | $1.02B |
| Cash & Equiv. | $802M | $10.68B | $6.47B | $1.11B |
NXE vs XOM vs CVX vs CCJ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NexGen Energy Ltd. (NXE) | 100 | 867.1 | +767.1% |
| Exxon Mobil Corpora… (XOM) | 100 | 317.6 | +217.6% |
| Chevron Corporation (CVX) | 100 | 197.9 | +97.9% |
| Cameco Corporation (CCJ) | 100 | 1074.1 | +974.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NXE vs XOM vs CVX vs CCJ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NXE is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.48, Low D/E 32.0%, current ratio 1.82x
- Beta 1.48, current ratio 1.82x
- Beta 1.48 vs CCJ's 1.72
XOM is the #2 pick in this set and the best alternative if value and efficiency is your priority.
- Lower P/E (14.8x vs 74.0x)
- 6.4% ROA vs NXE's -20.6%, ROIC 8.6% vs -4.9%
CVX is the clearest fit if your priority is income & stability.
- Dividend streak 8 yrs, beta -0.05, yield 3.8%
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (1 stock pays no dividend)
CCJ carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 10.9%, EPS growth 246.2%, 3Y rev CAGR 23.0%
- 9.3% 10Y total return vs NXE's 5.6%
- 10.9% revenue growth vs NXE's -351.0%
- 16.9% margin vs NXE's -1.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.9% revenue growth vs NXE's -351.0% | |
| Value | Lower P/E (14.8x vs 74.0x) | |
| Quality / Margins | 16.9% margin vs NXE's -1.2% | |
| Stability / Safety | Beta 1.48 vs CCJ's 1.72 | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +138.9% vs CVX's +39.5% | |
| Efficiency (ROA) | 6.4% ROA vs NXE's -20.6%, ROIC 8.6% vs -4.9% |
NXE vs XOM vs CVX vs CCJ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NXE vs XOM vs CVX vs CCJ — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCJ leads in 2 of 6 categories
CVX leads 1 • XOM leads 1 • NXE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CCJ leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM and NXE operate at a comparable scale, with $323.9B and $0 in trailing revenue. CCJ is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to CVX's 6.7%. On growth, CCJ holds the edge at +1.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $323.9B | $184.4B | $3.5B |
| EBITDAEarnings before interest/tax | -$96M | $59.9B | $37.1B | $912M |
| Net IncomeAfter-tax profit | -$415M | $28.8B | $12.3B | $589M |
| Free Cash FlowCash after capex | -$193M | $23.6B | $16.2B | $1.1B |
| Gross MarginGross profit ÷ Revenue | — | +21.7% | +30.4% | +29.4% |
| Operating MarginEBIT ÷ Revenue | — | +10.5% | +9.0% | +17.5% |
| Net MarginNet income ÷ Revenue | — | +8.9% | +6.7% | +16.9% |
| FCF MarginFCF ÷ Revenue | — | +7.3% | +8.8% | +30.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -1.3% | -5.3% | +1.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -166.7% | -11.0% | -24.5% | +45.2% |
Valuation Metrics
CVX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, XOM trades at a 82% valuation discount to CCJ's 119.9x P/E. On an enterprise value basis, CVX's 10.9x EV/EBITDA is more attractive than CCJ's 79.5x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $8.2B | $620.8B | $364.2B | $51.7B |
| Enterprise ValueMkt cap + debt − cash | $8.0B | $653.7B | $404.5B | $51.6B |
| Trailing P/EPrice ÷ TTM EPS | -32.48x | 21.86x | 27.53x | 119.93x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.79x | 15.02x | 74.01x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.91x | 10.89x | 79.53x |
| Price / SalesMarket cap ÷ Revenue | — | 1.92x | 1.97x | 20.26x |
| Price / BookPrice ÷ Book value/share | 5.43x | 2.37x | 1.76x | 10.22x |
| Price / FCFMarket cap ÷ FCF | — | 26.29x | 21.95x | 68.99x |
Profitability & Efficiency
XOM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
XOM delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-30 for NXE. CCJ carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXE's 0.32x. On the Piotroski fundamental quality scale (0–9), CCJ scores 8/9 vs XOM's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -30.3% | +10.7% | +7.2% | +8.8% |
| ROA (TTM)Return on assets | -20.6% | +6.4% | +4.2% | +6.0% |
| ROICReturn on invested capital | -4.9% | +8.6% | +6.2% | +6.3% |
| ROCEReturn on capital employed | -5.9% | +8.9% | +6.6% | +6.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 8 |
| Debt / EquityFinancial leverage | 0.32x | 0.16x | 0.24x | 0.15x |
| Net DebtTotal debt minus cash | -$215M | $32.9B | $40.3B | -$92M |
| Cash & Equiv.Liquid assets | $802M | $10.7B | $6.5B | $1.1B |
| Total DebtShort + long-term debt | $586M | $43.5B | $46.7B | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | -5.38x | 69.44x | 17.22x | 10.04x |
Total Returns (Dividends Reinvested)
CCJ leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CCJ five years ago would be worth $59,356 today (with dividends reinvested), compared to $19,396 for CVX. Over the past 12 months, CCJ leads with a +138.9% total return vs CVX's +39.5%. The 3-year compound annual growth rate (CAGR) favors CCJ at 63.0% vs CVX's 8.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.8% | +20.3% | +18.2% | +20.4% |
| 1-Year ReturnPast 12 months | +121.1% | +43.9% | +39.5% | +138.9% |
| 3-Year ReturnCumulative with dividends | +215.0% | +44.9% | +26.7% | +333.3% |
| 5-Year ReturnCumulative with dividends | +157.9% | +164.6% | +94.0% | +493.6% |
| 10-Year ReturnCumulative with dividends | +562.0% | +105.0% | +135.8% | +934.7% |
| CAGR (3Y)Annualised 3-year return | +46.6% | +13.2% | +8.2% | +63.0% |
Risk & Volatility
Evenly matched — NXE and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than CCJ's 1.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXE currently trades 88.7% from its 52-week high vs XOM's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.51x | -0.15x | -0.11x | 1.77x |
| 52-Week HighHighest price in past year | $13.96 | $176.41 | $214.71 | $135.24 |
| 52-Week LowLowest price in past year | $5.29 | $101.19 | $133.77 | $47.87 |
| % of 52W HighCurrent price vs 52-week peak | +88.7% | +83.0% | +85.0% | +87.7% |
| RSI (14)Momentum oscillator 0–100 | 57.5 | 42.4 | 42.1 | 56.1 |
| Avg Volume (50D)Average daily shares traded | 6.7M | 18.9M | 11.0M | 3.2M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NXE as "Buy", XOM as "Hold", CVX as "Buy", CCJ as "Buy". Consensus price targets imply 9.5% upside for XOM (target: $160) vs 4.6% for CVX (target: $191). For income investors, CVX offers the higher dividend yield at 3.76% vs CCJ's 0.15%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $160.43 | $190.93 | $125.91 |
| # AnalystsCovering analysts | 4 | 55 | 53 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | +2.7% | +3.8% | +0.1% |
| Dividend StreakConsecutive years of raises | — | 26 | 8 | 2 |
| Dividend / ShareAnnual DPS | — | $4.00 | $6.87 | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | +3.3% | 0.0% |
CCJ leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CVX leads in 1 (Valuation Metrics). 2 tied.
NXE vs XOM vs CVX vs CCJ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NXE or XOM or CVX or CCJ a better buy right now?
For growth investors, Cameco Corporation (CCJ) is the stronger pick with 10.
9% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate NexGen Energy Ltd. (NXE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NXE or XOM or CVX or CCJ?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
9x versus Cameco Corporation at 119. 9x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 14. 8x.
03Which is the better long-term investment — NXE or XOM or CVX or CCJ?
Over the past 5 years, Cameco Corporation (CCJ) delivered a total return of +493.
6%, compared to +94. 0% for Chevron Corporation (CVX). Over 10 years, the gap is even starker: CCJ returned +918. 3% versus XOM's +105. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NXE or XOM or CVX or CCJ?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Cameco Corporation's 1. 77β — meaning CCJ is approximately -1310% more volatile than XOM relative to the S&P 500. On balance sheet safety, Cameco Corporation (CCJ) carries a lower debt/equity ratio of 15% versus 32% for NexGen Energy Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — NXE or XOM or CVX or CCJ?
By revenue growth (latest reported year), Cameco Corporation (CCJ) is pulling ahead at 10.
9% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Cameco Corporation grew EPS 246. 2% year-over-year, compared to -271. 4% for NexGen Energy Ltd.. Over a 3-year CAGR, CCJ leads at 23. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NXE or XOM or CVX or CCJ?
Cameco Corporation (CCJ) is the more profitable company, earning 16.
9% net margin versus 0. 0% for NexGen Energy Ltd. — meaning it keeps 16. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCJ leads at 16. 7% versus 0. 0% for NXE. At the gross margin level — before operating expenses — CVX leads at 30. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NXE or XOM or CVX or CCJ more undervalued right now?
On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 14.
8x forward P/E versus 74. 0x for Cameco Corporation — 59. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 9. 5% to $160. 43.
08Which pays a better dividend — NXE or XOM or CVX or CCJ?
In this comparison, CVX (3.
8% yield), XOM (2. 7% yield), CCJ (0. 1% yield) pay a dividend. NXE does not pay a meaningful dividend and should not be held primarily for income.
09Is NXE or XOM or CVX or CCJ better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). NexGen Energy Ltd. (NXE) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (XOM: +105. 0%, NXE: +549. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NXE and XOM and CVX and CCJ?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NXE is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; CCJ is a mid-cap quality compounder stock. XOM, CVX pay a dividend while NXE, CCJ do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.